Co-Authors
This is a "connection" page, showing publications co-authored by Michael Silverberg and Jacek Skarbinski.
Connection Strength
0.754
-
Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 (COVID-19) Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout. Clin Infect Dis. 2023 Mar 02.
Score: 0.221
-
Influenza Vaccination Uptake and Associated Factors Among Adults With and Without HIV in a Large, Integrated Health Care System. Clin Infect Dis. 2023 Mar 01.
Score: 0.221
-
Differences in COVID-19 testing and adverse outcomes by race, ethnicity, sex, and health system setting in a large diverse US cohort. PLoS One. 2022; 17(11):e0276742.
Score: 0.054
-
Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US. JAMA Netw Open. 2022 10 03; 5(10):e2236397.
Score: 0.054
-
Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States. JAMA Netw Open. 2022 06 01; 5(6):e2215934.
Score: 0.052
-
SARS-CoV-2 testing and positivity among persons with and without HIV in 6 United States cohorts. J Acquir Immune Defic Syndr. 2022 Feb 21.
Score: 0.051
-
COVID-19 infections post-vaccination by HIV status in the United States. medRxiv. 2021 Dec 05.
Score: 0.051
-
Characterization of HIV Preexposure Prophylaxis Use Behaviors and HIV Incidence Among US Adults in an Integrated Health Care System. JAMA Netw Open. 2021 Aug 02; 4(8):e2122692.
Score: 0.050